首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1627篇
  免费   117篇
  国内免费   25篇
儿科学   146篇
妇产科学   15篇
基础医学   199篇
口腔科学   66篇
临床医学   153篇
内科学   351篇
皮肤病学   39篇
神经病学   25篇
特种医学   329篇
外科学   96篇
综合类   24篇
预防医学   65篇
眼科学   16篇
药学   151篇
  1篇
中国医学   1篇
肿瘤学   92篇
  2023年   3篇
  2022年   7篇
  2021年   15篇
  2020年   8篇
  2019年   14篇
  2018年   26篇
  2017年   20篇
  2016年   23篇
  2015年   32篇
  2014年   28篇
  2013年   53篇
  2012年   14篇
  2011年   17篇
  2010年   42篇
  2009年   79篇
  2008年   19篇
  2007年   44篇
  2006年   40篇
  2005年   37篇
  2004年   23篇
  2003年   26篇
  2002年   23篇
  2001年   23篇
  2000年   25篇
  1999年   38篇
  1998年   102篇
  1997年   121篇
  1996年   114篇
  1995年   78篇
  1994年   85篇
  1993年   101篇
  1992年   27篇
  1991年   18篇
  1990年   21篇
  1989年   50篇
  1988年   41篇
  1987年   33篇
  1986年   46篇
  1985年   35篇
  1984年   21篇
  1983年   19篇
  1982年   20篇
  1981年   39篇
  1980年   25篇
  1979年   18篇
  1978年   14篇
  1977年   30篇
  1976年   21篇
  1975年   9篇
  1970年   1篇
排序方式: 共有1769条查询结果,搜索用时 15 毫秒
101.
血清骨唾液酸蛋白的生物变异性研究   总被引:3,自引:0,他引:3       下载免费PDF全文
目的 骨唾液酸蛋白(Bone sialoprotein,简称BSP)是由成骨细胞分泌的一种非胶原蛋白质,反映骨转换和骨形成的指标。最近研究认为:血清BSP浓度可反映破骨细胞活性和骨吸收过程,也可能是一个骨吸收指标。本实验测定了血清BSP在人体内的生物变异性。方法 采用RIA 法测定了290例不同性别和年龄的正常人血清BSP的正常值,血清BSP的天-天变异性及24 h 生物周期。 结果 在儿童组血清BSP正常水平明显高于成人组,其最高值在新生儿期和青春期。绝经后妇女其血清浓度比绝经前妇女水平明显升高(P< 0.05)。血清BSP在每天同一时间的波动范围在 7.3% 至17.7% (平均11.7% )。24 h 内有一个明显的生物周期性变化,表现为峰值在凌晨4~8 时,然后逐渐下降直到午后14时为最低。其生物周期的最大波幅为±20% ,(平均血浓度为10.5 ng/m l)。结论 血清BSP反映了骨转换的生理变化与年龄有明显相关性,其血清水平24 h 内有一个明显的生物周期,而天与天之间变异性较小。  相似文献   
102.
Locally deranged joint anatomy can predispose to septic arthritis which can be managed by surgical debridement. We present a case of manubriosternal subluxation/dislocation caused by kyphoscoliosis leading to manubriosternal septic arthritis.  相似文献   
103.
104.
Aim: This study investigates the effect of rapid weight gain in term children, adolescents and young adults born appropriate for gestational age. Methods: In all, 173 girls and 178 boys aged 6.1–19.9 (12.5 ± 3.1)years participated. Rapid weight gain (group 1) was defined as a change in weight‐SDS (standard deviation score) from birth till two years >0.67, ‘no change’ as ≥?0.67 and ≤0.67 (group 2) vs ‘slow weight gain’ as 90th age‐/sex‐specific BMI‐percentile was defined as overweight. Parental BMI, socio‐economic status and lifestyle were assessed as confounders. Results: A total of 22.8% gained weight rapidly, and 15.7% was overweight. Group 1 compared with group 2 and 3 subjects was taller, heavier and had a higher prevalence of overweight (girls/boys: 26.2%/28.9% vs 11.6%/19.0% vs 2.8%/5.0%; p < 0.01/p < 0.05). Concomitantly, a higher WC, %FM and FFM were observed. Rapid weight gain was positively associated with REE (adjusted for FFM) in boys (r = 0.26; p < 0.01), but not with cardio‐metabolic risk factors. Conclusion: Rapid weight gain was related to increases in height, weight, a higher prevalence of overweight and central fat distribution. In addition, rapid weight gain was related to a higher REE in boys, but not to cardio‐metabolic risk factors.  相似文献   
105.
Introduction: There are several second-line treatment options for patients with renal cell carcinoma after first-line failure of a tyrosine kinase inhibitor, especially with the recent approvals of cabozantinib, nivolumab, and the lenvatinib plus everolimus combination. A lack of reliable biomarkers and an overall lack of prospective head-to-head comparisons make it a challenge to choose a second-line treatment in the clinic.

Areas covered: In this review/meta-opinion, we describe the safety profile of the lenvatinib plus everolimus combination in renal cell carcinoma. The combination of lenvatinib plus everolimus has achieved the highest rates of objective responses and the longest progression free and overall survival in cross-comparison trials. At the same time, the safety profile of this combination, including the rate of total and severe adverse events, the percentage of dose reductions required, and the rate of treatment discontinuation, was less favorable compared with available monotherapy options, suggesting that better management could help to maximize the activity of this combination while protecting patients from undue harm.

Expert opinion: Herein, we aim to postulate multidisciplinary recommendations on the advice to offer to patients and caregivers before starting treatment and how to manage the combination from the perspective of daily clinical practice.  相似文献   

106.
New N-methylpiperazino-substituted quinazolines 8 and 9, phthalazine 13, and quinoline 19 have been synthesized. The receptor binding profiles (α1, 5-HT1A, 5-HT2A) of these compounds and their analogs (7–22) have been determined. It has been demonstrated that orientation of a local dipole moment of the heteroaromatic ring system affects both the α1 and 5-HT2A affinity of the investigated class of ligands. Distortion of the coplanar unfused heteroaromatic ring system results in a decreased 5-HT2A affinity. 4-(4-Methylpiperazino)-2-(2-thienyl)quinoline 18 is the most active and selective α1 ligand (Ki = 4.9 nM) with a much lower affinity for 5-HT1A (Ki = 3420 nM) and 5-HT2A (Ki = 211 nM) receptors.  相似文献   
107.
108.

Background  

In this study we evaluated the usefulness of a free self-test for screening albuminuria in the general population.  相似文献   
109.

Background  

Many countries have introduced elements of managed competition in their healthcare system with the aim to accomplish more efficient and demand-driven health care. Simultaneously, generating and reporting of comparative healthcare information has become an important quality-improvement instrument. We examined whether the introduction of managed competition in the Dutch healthcare system along with public reporting of quality information was associated with performance improvement in health plans.  相似文献   
110.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号